Lilly, Boehringer copy of Sanofi's insulin gets EU approval

September 10, 2014 12:20 PM

13 0

Lilly, Boehringer copy of Sanofi's insulin gets EU approval

(Reuters) - Eli Lilly and Co and Boehringer Ingelheim said on Wednesday that the European Commission approved their copycat version of Sanofi SA's blockbuster insulin, Lantus.

The treatment, to be manufactured by Lilly, comprises a type of basal insulin, intended to provide long-lasting blood sugar control between meals and at night.

Also read: FDA OKs 2nd gene therapy for blood cancer; 1st for adults

Read more

To category page

Loading...